Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bruker Corporation - Common Stock (NQ: BRKR )

45.56 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker: Q2 Earnings Insights
Bruker (NASDAQ:BRKR) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Bruker reported in-line EPS of $0.45... 
Via Benzinga
Bruker: Q1 Earnings Insights
Bruker (NASDAQ:BRKR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Bruker Reports Second Quarter 2022 Financial Results
From Bruker Corporation
Via Business Wire
7 Nasdaq Stocks to Buy and Hold Forever
Investors should consider these Nasdaq stocks to buy and hold forever for portfolios that are diversified across several growing sectors. 
Via InvestorPlace
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics Research
From Bruker Corporation
Via Business Wire
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment
From Bruker Corporation
Via Business Wire
7 Stocks to Buy That Could Make You a Millionaire
These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments. 
Via InvestorPlace
Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics
From Bruker Corporation
Via Business Wire
Bruker Presents High-Value Life Science, Materials Research and Applied Market Solutions at Analytica 2022
From Bruker Corporation
Via Business Wire
Bruker Introduces Enhanced 3D Holographic Stimulation for Optogenetics on its Ultima 2Pplus Multiphoton Microscope
From Bruker Corporation
Via Business Wire
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
From Bruker Corporation
Via Business Wire
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
From Bruker Corporation
Via Business Wire
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
From Bruker Corporation
Via Business Wire
Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference
From Bruker Corporation
Via Business Wire
Bruker Announces Quarterly Dividend
From Bruker Corporation
Via Business Wire
Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets
From Bruker Corporation
Via Business Wire
Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets
From Bruker Corporation
Via Business Wire
Bruker Reports First Quarter Financial Results
From Bruker Corporation
Via Business Wire
Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet
From Bruker Corporation
Via Business Wire
Bruker Launches Unique LiquidArray® Multiplex PCR Assays
From Bruker Corporation
Via Business Wire
Bruker Announces Date and Time of First Quarter 2022 Earnings Release and Webcast
From Bruker Corporation
Via Business Wire
Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research
From Bruker Corporation
Via Business Wire
IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development
From IonSense Inc.
Via Business Wire
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
From Bruker Corporation
Via Business Wire
Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR
From Bruker Corporation
Via Business Wire
Bruker Appoints Philip Ma to its Board of Directors
From Bruker Corporation
Via Business Wire
Bruker Releases CCS-Enabled TIMScore™ and TIMS DIA-NN 4D Proteomics Software
From Bruker Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.